Barbara G. Werner

4.8k total citations · 1 hit paper
70 papers, 3.5k citations indexed

About

Barbara G. Werner is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Barbara G. Werner has authored 70 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Epidemiology, 19 papers in Infectious Diseases and 15 papers in Hepatology. Recurrent topics in Barbara G. Werner's work include Cytomegalovirus and herpesvirus research (22 papers), Hepatitis B Virus Studies (20 papers) and Hepatitis C virus research (13 papers). Barbara G. Werner is often cited by papers focused on Cytomegalovirus and herpesvirus research (22 papers), Hepatitis B Virus Studies (20 papers) and Hepatitis C virus research (13 papers). Barbara G. Werner collaborates with scholars based in United States, Germany and France. Barbara G. Werner's co-authors include David R. Snydman, Baruch S. Blumberg, M. E. Bayer, Matthew E. Falagas, John L. Griffith, Robin Ruthazer, Robert H. Rubin, Richard B. Freeman, Jesse Summers and Bernard Larouzé and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Barbara G. Werner

68 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant Recipients

1987 434 citations David R. Snydman, Barbara G. Werner et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Barbara G. Werner

Since Specialization

Citations

This map shows the geographic impact of Barbara G. Werner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara G. Werner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara G. Werner more than expected).

Fields of papers citing papers by Barbara G. Werner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara G. Werner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara G. Werner. The network helps show where Barbara G. Werner may publish in the future.

Co-authorship network of co-authors of Barbara G. Werner

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara G. Werner. A scholar is included among the top collaborators of Barbara G. Werner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara G. Werner. Barbara G. Werner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Survival outcomes of patients newly diagnosed with diffuse large B-cell lymphoma: real-world evidence from a German claims database 2023 ·Journal of Cancer Research and Clinical Oncology ·Peter Borchmann, Jan‐Michel Heger, Jörg Mahlich, (unknown), (unknown), Barbara G. Werner	7
2	Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Health Claims Data Analysis 2022 ·Oncology and Therapy ·Peter Borchmann, Jan‐Michel Heger, Jörg Mahlich, (unknown), (unknown), Barbara G. Werner	7
3	Acute infections, cost and time to reporting of HIV test results in three U.S. State Public Health Laboratories 2016 ·Journal of Infection ·Muazzam Nasrullah, Laura G. Wesolowski, Steven F. Ethridge, Kevin Cranston, Michael Pentella, Robert A. Myers, James T. Rudrik, Angela B. Hutchinson, (unknown), Barbara G. Werner	5
4	Hypogammaglobulinemia in Liver Transplant Recipients: Incidence, Timing, Risk Factors, and Outcomes 2006 ·Transplantation ·Shira Doron, Robin Ruthazer, Barbara G. Werner, Arthur R. Rabson, David R. Snydman	58
5	Histopathologically Proven Poliomyelitis with Quadriplegia and Loss of Brainstem Function Due to West Nile Virus Infection 2003 ·Clinical Infectious Diseases ·Shira Doron, John F. Dashe, Lester S. Adelman, William F. Brown, Barbara G. Werner, Susan Hadley	53
6	Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label study 2001 ·Transplantation Proceedings ·David R. Snydman, M. E. Falagas, Robin K. Avery, Carl A. Perlino, Robin Ruthazer, Richard B. Freeman, Richard Rohrer, (unknown), Edward J. OʼRourke, Patricia L. Hibberd, Barbara G. Werner	27
7	Family Studies of a Human Serum Isoantigen System (Australia Antigen) 2000 ·Europe PMC (PubMed Central) ·Baruch S. Blumberg, Liisa Melartin, (unknown), Barbara G. Werner	6
8	An Occupational Cohort Mortality Study of Women in the German Rubber Industry: 1976 to 1991 1999 ·Journal of Occupational and Environmental Medicine ·Kenneth A. Mundt, Stephan K. Weiland, (unknown), Kurt Straíf, Barbara G. Werner, Lloyd E. Chambless, Ulrich Keil	6
9	Human Herpesvirus 6 Reactivation Is Associated with Cytomegalovirus Infection and Syndromes in Kidney Transplant Recipients at Risk for Primary Cytomegalovirus Infection 1998 ·The Journal of Infectious Diseases ·Jeffrey A. DesJardin, Laurie Gibbons, (unknown), Stacey Supran, Matthew E. Falagas, Barbara G. Werner, David R. Snydman	113
10	SIGNIFICANCE OF CYTOMEGALOVIRUS FOR LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER TRANSPLANTATION 1998 ·Transplantation ·Matthew E. Falagas, Carlos V. Payá, Robin Ruthazer, Andrew D. Badley, Robin Patel, Russell H. Wiesner, John Griffith, Richard B. Freeman, Richard Rohrer, Barbara G. Werner, David R. Snydman	58
11	Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation 1997 ·Clinical Transplantation ·(unknown), David R. Snydman, Robin Ruthazer, John L. Griffith, Barbara G. Werner, Richard B. Freeman, Richard Rohrer	49
12	Surveillance Cultures of Blood, Urine, and Throat Specimens Are Not Valuable for Predicting Cytomegalovirus Disease in Liver Transplant Recipients 1997 ·Clinical Infectious Diseases ·Matthew E. Falagas, David R. Snydman, Robin Ruthazer, Barbara G. Werner, John L. Griffith	26
13	The Independent Role of Cytomegalovirus as a Risk Factor for Invasive Fungal Disease in Orthotopic Liver Transplant Recipients 1997 ·The American Journal of Medicine ·(unknown), David R. Snydman, Barbara G. Werner, John L. Griffith, Matthew E. Falagas, (unknown), Robert H. Rubin	245
14	Primary Cytomegalovirus Infection in Liver Transplant Recipients: Comparison of Infections Transmitted Via Donor Organs and Via Transfusions 1996 ·Clinical Infectious Diseases ·M. E. Falagas, David R. Snydman, Robin Ruthazer, John Griffith, Barbara G. Werner	19
15	Use of cytomegalovirus immunoglobulin in multiply transfused premature neonates 1995 ·The Pediatric Infectious Disease Journal ·David R. Snydman, Barbara G. Werner, H. Cody Meissner, Sarah H. Cheeseman, (unknown), Francis Bednarek, Joseph L. Kennedy, Marguerite Herschel, (unknown), Myron J. Levin, Timos Valaes, Eugene M. Berkman, James McIver, J. Leszczynski, John L. Griffith, George F. Grady	39
16	A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group. 1994 ·PubMed ·David R. Snydman, Barbara G. Werner, (unknown), John Griffith, Richard Rohrer, Richard B. Freeman, (unknown), (unknown), Edward J. OʼRourke	11
17	Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: A U.S. National Collaborative Study 1994 ·Kidney International ·Brian J.G. Pereira, Teresa L. Wright, Christopher H. Schmid, Christopher Bryan, Ramsey Cheung, (unknown), (unknown), (unknown), Jimmy A. Light, Douglas J. Norman, (unknown), Barbara G. Werner, Charles E. Wright, Andrew S. Levey	54
18	Cytomegalovirus Immune Globulin Prophylaxis in Liver Transplantation 1993 ·Annals of Internal Medicine ·David R. Snydman, Barbara G. Werner, (unknown), John L. Griffith, R. H. Rubin, Jules L. Dienstag, Richard Rohrer, Richard B. Freeman, Roger L. Jenkins, (unknown), Stefanie Hammer, Edward J. OʼRourke, G. F. Grady, Khaled Fawaz, Marshall M. Kaplan, Mark A. Hoffman, (unknown), Maureen Doran	160
19	WHICH RENAL TRANSPLANT PATIENTS SHOULD RECEIVE CYTOMEGALOVIRUS IMMUNE GLOBULIN? 1991 ·Transplantation ·Joel Tsevat, David R. Snydman, Stephen G. Pauker, Isabelle Durand‐Zaleski, Barbara G. Werner, Andrew S. Levey	36
20	Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant Recipients breakdown → 1987 ·New England Journal of Medicine ·David R. Snydman, Barbara G. Werner, Beverly Heinze-Lacey, Victor P. Berardi, N. L. Tilney, (unknown), Edgar L. Milford, Sung‐Il Cho, Harry L. Bush, Andrew S. Levey, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	434

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact